IMDX

$0.00

(

0.00%

)
Quote details

stock

Insight Molecular Diagnostics Inc.

NASDAQ | IMDX

6.35

USD

$0.00

(

0.00%

)

At Close (As of Oct 24, 2025)

$86.66M

Market Cap

-

P/E Ratio

-3.79

EPS

$6.63

52 Week High

$1.92

52 Week Low

HEALTHCARE

Sector

IMDX Chart

Recent Chart
Price Action

IMDX Technicals

Tags:

IMDX Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $740K
Total Revenue $1.9M
Cost Of Revenue $1.1M
Costof Goods And Services Sold $1.1M
Operating Income -$61M
Selling General And Administrative $13M
Research And Development $9.8M
Operating Expenses $62M
Investment Income Net -
Net Interest Income -$84K
Interest Income -
Interest Expense $84K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax -$61M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$61M
Comprehensive Income Net Of Tax -
Ebit -$61M
Ebitda -$59M
Net Income -$61M

Revenue & Profitability

Earnings Performance

IMDX Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $35M
Total Current Assets $12M
Cash And Cash Equivalents At Carrying Value $8.6M
Cash And Short Term Investments $8.6M
Inventory $410K
Current Net Receivables $1.6M
Total Non Current Assets $23M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $15M
Intangible Assets Excluding Goodwill $15M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $1.1M
Other Non Current Assets -
Total Liabilities $47M
Total Current Liabilities $7.3M
Current Accounts Payable $2.3M
Deferred Revenue -
Current Debt -
Short Term Debt $1.3M
Total Non Current Liabilities $40M
Capital Lease Obligations $3.7M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $3.7M
Other Current Liabilities $3.7M
Other Non Current Liabilities $38M
Total Shareholder Equity -$12M
Treasury Stock -
Retained Earnings -$351M
Common Stock $338M
Common Stock Shares Outstanding $13M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$21M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $1.6M
Capital Expenditures $516K
Change In Receivables -
Change In Inventory -$410K
Profit Loss -
Cashflow From Investment -$512K
Cashflow From Financing $20M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$5.4M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$61M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $740K
Total Revenue $1.9M
Cost Of Revenue $1.1M
Costof Goods And Services Sold $1.1M
Operating Income -$61M
Selling General And Administrative $13M
Research And Development $9.8M
Operating Expenses $62M
Investment Income Net -
Net Interest Income -$84K
Interest Income -
Interest Expense $84K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $1.6M
Income Before Tax -$61M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$61M
Comprehensive Income Net Of Tax -
Ebit -$61M
Ebitda -$59M
Net Income -$61M

IMDX News

IMDX Profile

Insight Molecular Diagnostics Inc. Profile

Sector: HEALTHCARE

Industry: DIAGNOSTICS & RESEARCH

Insight Molecular Diagnostics Inc. (IMDX) is a leading precision diagnostics company headquartered in Irvine, California, focused on transforming the landscape of molecular testing to improve patient care. The company specializes in developing cutting-edge diagnostic solutions that target critical unmet needs in oncology, leveraging innovative technologies to provide accurate and timely testing results. With a strong commitment to enhancing disease detection and patient outcomes, IMDX is strategically positioned to make a substantial impact in the burgeoning field of personalized medicine, both domestically and internationally.

WGRX
+200.32%
$1.21
BYND
-9.57%
$2.56
TOVX
+95.58%
$0.66
YYAI
-15.09%
$0.07
VIVK
+49.53%
$0.38
CGBS
-39.47%
$0.03
F
+10.29%
$13.61
YDKG
-16.43%
$0.06
VHAI
0.00%
$0.00
INTC
+0.27%
$38.26
DVLT
+50.44%
$3.38
BURU
-5.27%
$0.34
BITF
+5.71%
$4.16
IONZ
-14.59%
$3.98
NEUP
+49.62%
$6.06
AXDX
-61.36%
$0.03
ADTX
-5.15%
$0.28
NVDA
+1.66%
$185.18
AAL
+8.00%
$13.79
PLUG
-1.36%
$2.88
RGTI
+2.39%
$40.54
QUBT
+7.19%
$15.94
RIG
+1.79%
$3.96
VZ
-3.51%
$38.40
SCNX
-36.15%
$1.65
QLGN
+6.53%
$3.76
TSLA
-2.32%
$438.55
JOBY
+1.29%
$15.67
DNN
+2.32%
$2.79
QBTS
+8.75%
$33.77
NOK
+1.54%
$6.26
AMD
+6.14%
$249.42
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ONDS
+9.06%
$7.70
SRM
+53.27%
$10.30
SOFI
+3.93%
$29.18
T
+1.96%
$25.10
WTO
-10.34%
$0.06
AMC
-0.72%
$2.73
ADAP
-4.14%
$0.06
RF
+1.34%
$24.42
CAN
+6.22%
$1.86
NUAI
+43.86%
$5.68
CIFR
+18.52%
$20.45
CUTR
-10.19%
$0.09
AIRE
-15.81%
$0.83
WLGS
-5.57%
$0.04
ETHD
-0.62%
$3.94
LUV
-6.25%
$31.65
ETWO
0.00%
$3.30
ACHR
+3.75%
$11.32
NIO
+1.37%
$6.98
ASST
+6.45%
$0.92
TLRY
+1.68%
$1.50
CLOV
+18.90%
$3.80
AFMD
-34.94%
$0.18
IREN
+8.57%
$60.65
PLTR
+2.77%
$185.49
GRAB
+2.06%
$5.83
KDLY
+10.41%
$0.79
ELBM
+3.61%
$1.72
SNAP
+0.50%
$7.91
LAES
+8.93%
$6.23
PCG
-1.68%
$16.30
QS
+9.82%
$16.10
PBR
+0.08%
$11.85
GPUS
-0.23%
$0.38
BTBT
+6.85%
$3.97
OPI
-16.97%
$0.20
BULL
+2.30%
$11.08
RXRX
+1.65%
$5.82
RGTZ
-4.19%
$14.27
KLG
-9.05%
$13.35
AMZN
+1.62%
$224.69
NVTS
+7.71%
$14.66
GRYP
-10.38%
$1.38
BBD
-0.10%
$3.34
GNTA
+96.59%
$6.35
MODV
-25.22%
$0.43
IONQ
+3.96%
$61.72
UUUU
-0.11%
$21.23
MARA
+1.90%
$19.58
APLD
+2.93%
$34.36
BTG
-0.19%
$5.22
NRXS
-5.10%
$3.62
LAZR
+23.66%
$2.09
WU
+10.24%
$8.97
ABEV
0.00%
$2.21
DFLI
+12.38%
$1.27
RVPH
+16.12%
$0.65
XFOR
+27.50%
$3.94
RR
+9.31%
$5.92
EOSE
-4.64%
$14.36
SMR
+2.05%
$38.33
BMNR
+2.29%
$50.31
GOOGL
+3.14%
$261.05
UAMY
-10.52%
$11.73
ERIC
-0.36%
$9.44
HOOD
+3.45%
$138.96
WGRX
+200.32%
$1.21
BYND
-9.57%
$2.56
TOVX
+95.58%
$0.66
YYAI
-15.09%
$0.07
VIVK
+49.53%
$0.38
CGBS
-39.47%
$0.03
F
+10.29%
$13.61
YDKG
-16.43%
$0.06
VHAI
0.00%
$0.00
INTC
+0.27%
$38.26
DVLT
+50.44%
$3.38
BURU
-5.27%
$0.34
BITF
+5.71%
$4.16
IONZ
-14.59%
$3.98
NEUP
+49.62%
$6.06
AXDX
-61.36%
$0.03
ADTX
-5.15%
$0.28
NVDA
+1.66%
$185.18
AAL
+8.00%
$13.79
PLUG
-1.36%
$2.88
RGTI
+2.39%
$40.54
QUBT
+7.19%
$15.94
RIG
+1.79%
$3.96
VZ
-3.51%
$38.40
SCNX
-36.15%
$1.65
QLGN
+6.53%
$3.76
TSLA
-2.32%
$438.55
JOBY
+1.29%
$15.67
DNN
+2.32%
$2.79
QBTS
+8.75%
$33.77
NOK
+1.54%
$6.26
AMD
+6.14%
$249.42
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
ONDS
+9.06%
$7.70
SRM
+53.27%
$10.30
SOFI
+3.93%
$29.18
T
+1.96%
$25.10
WTO
-10.34%
$0.06
AMC
-0.72%
$2.73
ADAP
-4.14%
$0.06
RF
+1.34%
$24.42
CAN
+6.22%
$1.86
NUAI
+43.86%
$5.68
CIFR
+18.52%
$20.45
CUTR
-10.19%
$0.09
AIRE
-15.81%
$0.83
WLGS
-5.57%
$0.04
ETHD
-0.62%
$3.94
LUV
-6.25%
$31.65
ETWO
0.00%
$3.30
ACHR
+3.75%
$11.32
NIO
+1.37%
$6.98
ASST
+6.45%
$0.92
TLRY
+1.68%
$1.50
CLOV
+18.90%
$3.80
AFMD
-34.94%
$0.18
IREN
+8.57%
$60.65
PLTR
+2.77%
$185.49
GRAB
+2.06%
$5.83
KDLY
+10.41%
$0.79
ELBM
+3.61%
$1.72
SNAP
+0.50%
$7.91
LAES
+8.93%
$6.23
PCG
-1.68%
$16.30
QS
+9.82%
$16.10
PBR
+0.08%
$11.85
GPUS
-0.23%
$0.38
BTBT
+6.85%
$3.97
OPI
-16.97%
$0.20
BULL
+2.30%
$11.08
RXRX
+1.65%
$5.82
RGTZ
-4.19%
$14.27
KLG
-9.05%
$13.35
AMZN
+1.62%
$224.69
NVTS
+7.71%
$14.66
GRYP
-10.38%
$1.38
BBD
-0.10%
$3.34
GNTA
+96.59%
$6.35
MODV
-25.22%
$0.43
IONQ
+3.96%
$61.72
UUUU
-0.11%
$21.23
MARA
+1.90%
$19.58
APLD
+2.93%
$34.36
BTG
-0.19%
$5.22
NRXS
-5.10%
$3.62
LAZR
+23.66%
$2.09
WU
+10.24%
$8.97
ABEV
0.00%
$2.21
DFLI
+12.38%
$1.27
RVPH
+16.12%
$0.65
XFOR
+27.50%
$3.94
RR
+9.31%
$5.92
EOSE
-4.64%
$14.36
SMR
+2.05%
$38.33
BMNR
+2.29%
$50.31
GOOGL
+3.14%
$261.05
UAMY
-10.52%
$11.73
ERIC
-0.36%
$9.44
HOOD
+3.45%
$138.96

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.